ARMP logo

Armata Pharmaceuticals (ARMP) Current Liabilities

Annual Current Liabilities

$16.46 M
-$8.41 M-33.82%

31 December 2023

ARMP Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Liabilities

$118.20 M
-$4.98 M-4.04%

30 September 2024

ARMP Quarterly Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ARMP Current Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-33.8%+440.1%
3 y3 years+145.5%+2149.8%
5 y5 years+540.0%+2280.8%

ARMP Current Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-33.8%+241.9%-4.0%+2355.4%
5 y5 years-33.8%+540.0%-4.0%+2355.4%
alltimeall time-33.8%+1729.0%-4.0%>+9999.0%

Armata Pharmaceuticals Current Liabilities History

DateAnnualQuarterly
Sept 2024
-
$118.20 M(-4.0%)
June 2024
-
$123.18 M(+11.9%)
Mar 2024
-
$110.05 M(+568.5%)
Dec 2023
$16.46 M(-33.8%)
$16.46 M(-24.8%)
Sept 2023
-
$21.88 M(-57.6%)
June 2023
-
$51.56 M(+0.3%)
Mar 2023
-
$51.41 M(+106.7%)
Dec 2022
$24.87 M(+416.7%)
$24.87 M(+255.1%)
Sept 2022
-
$7.00 M(-5.1%)
June 2022
-
$7.38 M(+18.6%)
Mar 2022
-
$6.23 M(+29.3%)
Dec 2021
$4.81 M(-28.2%)
$4.81 M(-8.4%)
Sept 2021
-
$5.25 M(-11.0%)
June 2021
-
$5.90 M(+18.5%)
Mar 2021
-
$4.98 M(-25.7%)
Dec 2020
$6.71 M(+37.4%)
$6.71 M(-5.2%)
Sept 2020
-
$7.07 M(+35.8%)
June 2020
-
$5.21 M(-18.1%)
Mar 2020
-
$6.36 M(+30.3%)
Dec 2019
$4.88 M(+89.7%)
$4.88 M(-1.7%)
Sept 2019
-
$4.96 M(-11.9%)
June 2019
-
$5.63 M(+56.9%)
Mar 2019
-
$3.59 M(+39.6%)
Dec 2018
$2.57 M(+30.7%)
$2.57 M(+4.3%)
Sept 2018
-
$2.46 M(+20.3%)
June 2018
-
$2.05 M(+15.4%)
Mar 2018
-
$1.77 M(-9.8%)
Dec 2017
$1.97 M(-44.4%)
$1.97 M(-20.5%)
Sept 2017
-
$2.48 M(-33.3%)
June 2017
-
$3.71 M(+29.0%)
Mar 2017
-
$2.88 M(-18.7%)
Dec 2016
$3.54 M(+48.3%)
$3.54 M(+12.2%)
Sept 2016
-
$3.15 M(-5.1%)
June 2016
-
$3.32 M(+25.4%)
Mar 2016
-
$2.65 M(+11.2%)
Dec 2015
$2.38 M(+27.7%)
$2.38 M(+5.6%)
Sept 2015
-
$2.26 M(+4.2%)
June 2015
-
$2.17 M(+2.1%)
Mar 2015
-
$2.12 M(+13.6%)
Dec 2014
$1.87 M(-21.9%)
$1.87 M(-25.3%)
Sept 2014
-
$2.50 M(+82.9%)
June 2014
-
$1.37 M(+55.4%)
Mar 2014
-
$879.00 K(-63.2%)
Dec 2013
$2.39 M(-60.5%)
$2.39 M(+33.1%)
Dec 2012
$6.05 M(+51.8%)
-
Sept 2009
-
$1.80 M(-10.5%)
June 2009
-
$2.01 M(-51.1%)
Mar 2009
-
$4.11 M(+3.1%)
Dec 2008
$3.99 M(-14.4%)
$3.99 M(-22.5%)
Sept 2008
-
$5.14 M(-14.1%)
June 2008
-
$5.98 M(+57.3%)
Mar 2008
-
$3.80 M(-18.3%)
Dec 2007
$4.66 M
$4.66 M(-9.1%)
Sept 2007
-
$5.13 M(-22.3%)
DateAnnualQuarterly
June 2007
-
$6.60 M(+13.5%)
Mar 2007
-
$5.81 M(+12.0%)
Dec 2006
$5.19 M(+12.1%)
$5.19 M(-21.0%)
Sept 2006
-
$6.57 M(+64.2%)
June 2006
-
$4.00 M(+2.1%)
Mar 2006
-
$3.92 M(-15.4%)
Dec 2005
$4.63 M(+15.8%)
$4.63 M(+25.6%)
Sept 2005
-
$3.69 M(-19.5%)
June 2005
-
$4.58 M(+13.2%)
Mar 2005
-
$4.04 M(+1.2%)
Dec 2004
$4.00 M(-40.5%)
$4.00 M(-17.6%)
Sept 2004
-
$4.85 M(-41.8%)
June 2004
-
$8.33 M(+11.4%)
Mar 2004
-
$7.47 M(+11.4%)
Dec 2003
$6.71 M(-40.5%)
$6.71 M(-10.2%)
Sept 2003
-
$7.47 M(-32.9%)
June 2003
-
$11.14 M(+9.3%)
Mar 2003
-
$10.20 M(-9.6%)
Dec 2002
$11.28 M(-3.0%)
$11.28 M(-9.3%)
Sept 2002
-
$12.44 M(+0.5%)
June 2002
-
$12.38 M(+26.2%)
Mar 2002
-
$9.80 M(-15.7%)
Dec 2001
$11.63 M(-8.3%)
$11.63 M(+12.3%)
Sept 2001
-
$10.36 M(-4.7%)
June 2001
-
$10.86 M(-23.4%)
Mar 2001
-
$14.18 M(+11.8%)
Dec 2000
$12.69 M(+175.8%)
$12.69 M(+77.4%)
Sept 2000
-
$7.15 M(+61.7%)
June 2000
-
$4.42 M(+6.6%)
Mar 2000
-
$4.15 M(-9.7%)
Dec 1999
$4.60 M(+39.4%)
$4.60 M(+43.8%)
Sept 1999
-
$3.20 M(0.0%)
June 1999
-
$3.20 M(+10.3%)
Mar 1999
-
$2.90 M(-12.1%)
Dec 1998
$3.30 M(+22.2%)
$3.30 M(+17.9%)
Sept 1998
-
$2.80 M(-3.4%)
June 1998
-
$2.90 M(-9.4%)
Mar 1998
-
$3.20 M(+18.5%)
Dec 1997
$2.70 M(-22.9%)
$2.70 M(0.0%)
Sept 1997
-
$2.70 M(-3.6%)
June 1997
-
$2.80 M(-6.7%)
Mar 1997
-
$3.00 M(-14.3%)
Dec 1996
$3.50 M(+94.4%)
$3.50 M(+20.7%)
Sept 1996
-
$2.90 M(-23.7%)
June 1996
-
$3.80 M(+137.5%)
Mar 1996
-
$1.60 M(-11.1%)
Dec 1995
$1.80 M(+12.5%)
$1.80 M(+38.5%)
Sept 1995
-
$1.30 M(0.0%)
June 1995
-
$1.30 M(0.0%)
Mar 1995
-
$1.30 M(-18.8%)
Dec 1994
$1.60 M(+77.8%)
$1.60 M(+23.1%)
Sept 1994
-
$1.30 M(-7.1%)
June 1994
-
$1.40 M(+55.6%)
Dec 1993
$900.00 K
$900.00 K

FAQ

  • What is Armata Pharmaceuticals annual total current liabilities?
  • What is the all time high annual current liabilities for Armata Pharmaceuticals?
  • What is Armata Pharmaceuticals annual current liabilities year-on-year change?
  • What is Armata Pharmaceuticals quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Armata Pharmaceuticals?
  • What is Armata Pharmaceuticals quarterly current liabilities year-on-year change?

What is Armata Pharmaceuticals annual total current liabilities?

The current annual current liabilities of ARMP is $16.46 M

What is the all time high annual current liabilities for Armata Pharmaceuticals?

Armata Pharmaceuticals all-time high annual total current liabilities is $24.87 M

What is Armata Pharmaceuticals annual current liabilities year-on-year change?

Over the past year, ARMP annual total current liabilities has changed by -$8.41 M (-33.82%)

What is Armata Pharmaceuticals quarterly total current liabilities?

The current quarterly current liabilities of ARMP is $118.20 M

What is the all time high quarterly current liabilities for Armata Pharmaceuticals?

Armata Pharmaceuticals all-time high quarterly total current liabilities is $123.18 M

What is Armata Pharmaceuticals quarterly current liabilities year-on-year change?

Over the past year, ARMP quarterly total current liabilities has changed by +$96.32 M (+440.14%)